Strategic Objectives
• Understand the chemical mechanics of C-to-T and A-to-G conversions.
• Explore the role of deaminase enzymes in non-destructive editing.
• Identify therapeutic applications for curing point-mutation diseases.
• Navigate the technical transition from DNA fracturing to base-pair correction.
The Core Challenge
Traditional CRISPR methods rely on double-strand breaks that risk genomic instability and unpredictable mutations.
01
The Dawn of Precision
02
The DNA Architecture
03
The CRISPR Revolution
04
Beyond the Break
05
The Chemistry of Deamination
06
Cytidine Base Editors
07
Adenine Base Editors
08
The Role of Cas9 Nickase
09
Targeting the Window
10
The UGI Factor
11
Off-Target Effects
12
Molecular Evolution
13
Point Mutations and Disease
14
RNA Base Editing
15
Prime Editing
16
Delivery Systems
17
Agricultural Innovations
18
Therapeutic Pipelines
19
Ethical Considerations
20
Regulatory Landscapes
21